Barely Significant
← all excerpts

Nafamostat reduces systemic inflammation in TLR7-mediated virus-like illness.

J Neuroinflammation · 2022 · PMC8734544 · PMID 34991643

Europe PMCDOI
1
hedged sentence
0.0570
closest p · 1.1× alpha
0.0570
boldest claim

The sentences

approached significancep = 0.057so close (0.05 < p ≤ 0.1)
An interaction between the R848 challenge and nafamostat treatment approached significance ( p = 0.057); Sidak’s post-hoc test of challenged animals revealed a significant decrease in TNF expression with nafamostat treatment (p < 0.01).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.